Paul Thomas

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA.

Surgalign Spine Technologies, Inc. is a global surgical implant company providing surgeons with biologic, metal and synthetic implants. It operates through the following business lines: Spine, Original Equipment Manufacturer (OEM), Sports and International. The Spine business line designs, manufactures, and distributes surgical implants, instruments, and biologics used in the treatment of conditions affecting the spine caused by degenerative conditions, deformities or traumatic injury. The OEM business line market and distributes the implants and instruments. The Sports business line deals with sports-related injuries that can be addressed with allograft implants. The International business line markets and distributes products through a direct distribution organization and a network of independent distributors from foreign affiliates. The company was founded in 1997 and is headquartered in Alachua, FL.

Cohera Medical, Inc. develops surgical adhesives and sealants. Its flagship product, TissuGlu, is an internal surgical adhesive used for large flap surgical operations like tummy tucks which lessens or even eliminates the accumulation of fluid and the need to undertake post surgical drains. The firm also offers Sylys Surgical Sealant, an adhesive that lessens anastomotic leakage in intestinal anastomosis procedures. The company was founded by Eric Beckman and Michael J. Buckley in 2006 and is headquartered in Raleigh, NC.

Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. Its products portfolio include cervical fixation, The Streamline (TL) fixation, motion preservation, orthobiologics, cervical inter-body fusion, TL IBF, and SI joint fusion. It offers coflex interlaminar stabilization device, SImmetry sacroiliac joint fusion system, and Fortilink IBF system with TETRAfuse?3D technology. The company was founded on February 12, 1998 and is headquartered in Deerfield, IL.

Prominex, Inc. manufactures molecular diagnostic assays for infectious disease testing. The company was founded by Paul Thomas and Paul Gargan in 2017 and is headquartered in San Diego, CA.

Ohmeda Medical, Inc. is an American company that wholesales health products.

Roka Bioscience, Inc. is a company that specializes in food safety technology. The company is based in Mendham, NJ and was founded in 2009 by Paul G. Thomas. Roka Bioscience's core technology is their pathogen detection assays which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to target ribosomal RNA (rRNA), an optimal target for molecular technology in food pathogen detection applications. The company offers a range of products including the Atlas® System and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bioscience also provides environmental testing solutions and technical support for their customers. Mary Duseau has been the CEO of the company since 2015.